Beijing Balance Medical Technology Co

Beijing Balance Medical Technology Co Net Margin

The Net Profit Margin of Beijing Balance Medical Technology Co (688198.SS) as of Nov 2, 2026 is 31.21 %. In the previous year, Net Profit Margin was 29.16 % — a change of 7.05% (higher).

Net Margin

31.21 %

YoY

7.05%

Last updated:

Net Profit Margin of Beijing Balance Medical Technology Co is 2025 31.21 % . Net Profit Margin of Beijing Balance Medical Technology Co was 2024 29.16 % . It decreases by 7.05% higher compared to the previous year.

Beijing Balance Medical Technology Co's net margin stands at 31.2%, up from 20.3% several years earlier.

The Beijing Balance Medical Technology Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
30.19 CNY
Jan 1, 2019
43.20 CNY
Jan 1, 2020
31.07 CNY
Jan 1, 2021
20.33 CNY
Jan 1, 2022
32.23 CNY
Jan 1, 2023
31.08 CNY
Jan 1, 2024
29.16 CNY
Jan 1, 2025
31.21 CNY
The Beijing Balance Medical Technology Co Net Margin history
YEARNet MarginYoY
31.21 %+7.05%
29.16 %-6.20%
31.08 %-3.56%
32.23 %+58.53%
20.33 %-34.57%
31.07 %-28.07%
43.20 %+43.11%
30.19 %-33.95%
45.70 %+15.02%
39.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Balance Medical Technology Co Stock analysis

What does Beijing Balance Medical Technology Co do? Beijing Balance Medical Technology Co., Ltd. generates revenue through the manufacture and sale of biotechnology products across three key therapeutic areas. The company's heart valve replacement and repair segment offers artificial biological heart valves and valve forming rings, while its congenital heart disease interventional therapy line includes cardiothoracic surgical biological patches, outflow tract single valve patches, and atrial defect occluders. The surgical soft tissue repair division provides neurosurgical biological patches and biological hernia patches. All products are sold primarily within China's domestic market to hospitals and medical institutions seeking advanced cardiovascular and surgical solutions. The firm's product portfolio targets medical professionals specializing in cardiac surgery, congenital heart defect correction, and soft tissue repair procedures. Hospitals and healthcare providers in China purchase these biotechnology solutions for patient treatments, with the domestic market serving as the primary sales channel. The company's focus on specialized medical devices for heart valve procedures, congenital heart conditions, and surgical repair applications drives its revenue streams. Beijing Balance Medical Technology's business model centers on developing and distributing high-precision medical devices tailored to specific surgical needs. The domestic Chinese healthcare system represents the main customer segment, with hospitals and clinics purchasing the company's products for use in cardiac surgeries, congenital heart defect corrections, and soft tissue repair operations. The company's product range directly supports medical procedures requiring biological heart valves, congenital heart disease interventions, and surgical tissue repair solutions. Beijing Balance Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Balance Medical Technology Co stock

Net Profit Margin of Beijing Balance Medical Technology Co is 31.21 % in 2025.

Net Profit Margin of Beijing Balance Medical Technology Co changed from 29.16 % to 31.21 %, representing a 7.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Beijing Balance Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Beijing Balance Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Beijing Balance Medical Technology Co

All Key Metrics — Beijing Balance Medical Technology Co